These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 15669896

  • 1. Beneficial effect of donepezil in the treatment of elderly patients with tardive movement disorders.
    Bergman J, Dwolatzky T, Brettholz I, Lerner V.
    J Clin Psychiatry; 2005 Jan; 66(1):107-10. PubMed ID: 15669896
    [Abstract] [Full Text] [Related]

  • 2. Treatment of tardive dyskinesia with donepezil: a pilot study.
    Caroff SN, Campbell EC, Havey J, Sullivan KA, Mann SC, Gallop R.
    J Clin Psychiatry; 2001 Oct; 62(10):772-5. PubMed ID: 11816865
    [Abstract] [Full Text] [Related]

  • 3. Treatment of tardive dyskinesia with donepezil.
    Caroff SN, Campbell EC, Havey JC, Sullivan KA, Katz IR, Mann SC.
    J Clin Psychiatry; 2001 Feb; 62(2):128-9. PubMed ID: 11247101
    [No Abstract] [Full Text] [Related]

  • 4. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.
    Spivak B, Mester R, Abesgaus J, Wittenberg N, Adlersberg S, Gonen N, Weizman A.
    J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253
    [Abstract] [Full Text] [Related]

  • 5. Effect of donepezil added to atypical antipsychotics on cognition in patients with schizophrenia: an open-label trial.
    Chung YC, Lee CR, Park TW, Yang KH, Kim KW.
    World J Biol Psychiatry; 2009 Jul; 10(2):156-62. PubMed ID: 19514097
    [Abstract] [Full Text] [Related]

  • 6. Effect of donepezil on tardive dyskinesia.
    Ogunmefun A, Hasnain M, Alam A, Osuala T, Regenold WT.
    J Clin Psychopharmacol; 2009 Feb; 29(1):102-4. PubMed ID: 19142126
    [No Abstract] [Full Text] [Related]

  • 7. Donepezil for negative signs in elderly patients with schizophrenia: an add-on, double-blind, crossover, placebo-controlled study.
    Mazeh D, Zemishlani H, Barak Y, Mirecki I, Paleacu D.
    Int Psychogeriatr; 2006 Sep; 18(3):429-36. PubMed ID: 16478570
    [Abstract] [Full Text] [Related]

  • 8. Treatment of tardive dyskinesia with galantamine: a randomized controlled crossover trial.
    Caroff SN, Walker P, Campbell C, Lorry A, Petro C, Lynch K, Gallop R.
    J Clin Psychiatry; 2007 Mar; 68(3):410-5. PubMed ID: 17388711
    [Abstract] [Full Text] [Related]

  • 9. A single-blind, randomized trial comparing quetiapine and haloperidol in the treatment of tardive dyskinesia.
    Emsley R, Turner HJ, Schronen J, Botha K, Smit R, Oosthuizen PP.
    J Clin Psychiatry; 2004 May; 65(5):696-701. PubMed ID: 15163258
    [Abstract] [Full Text] [Related]

  • 10. Beneficial effect of donepezil augmentation for the management of comorbid schizophrenia and dementia.
    Stryjer R, Strous RD, Bar F, Werber E, Shaked G, Buhiri Y, Kotler M, Weizman A, Rabey JM.
    Clin Neuropharmacol; 2003 May; 26(1):12-7. PubMed ID: 12567159
    [Abstract] [Full Text] [Related]

  • 11. Novel antipsychotics, extrapyramidal side effects and tardive dyskinesia.
    Barnes TR, McPhillips MA.
    Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S49-57. PubMed ID: 9690971
    [Abstract] [Full Text] [Related]

  • 12. Donepezil augmentation of clozapine monotherapy in schizophrenia patients: a double blind cross-over study.
    Stryjer R, Strous R, Bar F, Shaked G, Shiloh R, Rozencwaig S, Grupper D, Buchman N, Kotler M, Rabey JM, Weizman A.
    Hum Psychopharmacol; 2004 Jul; 19(5):343-6. PubMed ID: 15252826
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial.
    Keefe RS, Malhotra AK, Meltzer HY, Kane JM, Buchanan RW, Murthy A, Sovel M, Li C, Goldman R.
    Neuropsychopharmacology; 2008 May; 33(6):1217-28. PubMed ID: 17625502
    [Abstract] [Full Text] [Related]

  • 14. Neuroleptic drug-induced extrapyramidal syndromes and tardive dyskinesia.
    Casey DE.
    Schizophr Res; 1991 May; 4(2):109-20. PubMed ID: 1674881
    [Abstract] [Full Text] [Related]

  • 15. Vitamin B6 in treatment of tardive dyskinesia: a preliminary case series study.
    Lerner V, Kaptsan A, Miodownik C, Kotler M.
    Clin Neuropharmacol; 1999 May; 22(4):241-3. PubMed ID: 10442256
    [Abstract] [Full Text] [Related]

  • 16. Is donepezil useful for improving cognitive dysfunction in bipolar disorder?
    Kelly T.
    J Affect Disord; 2008 Apr; 107(1-3):237-40. PubMed ID: 17825922
    [Abstract] [Full Text] [Related]

  • 17. Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia.
    Sirota P, Mosheva T, Shabtay H, Giladi N, Korczyn AD.
    Am J Psychiatry; 2000 Feb; 157(2):287-9. PubMed ID: 10671405
    [Abstract] [Full Text] [Related]

  • 18. The prevalence of tardive dyskinesia after a nine month naturalistic randomized trial comparing olanzapine with conventional treatment for schizophrenia and related disorders.
    de Jesus Mari J, Lima MS, Costa AN, Alexandrino N, Rodrigues-Filho S, de Oliveira IR, Tollefson GD.
    Eur Arch Psychiatry Clin Neurosci; 2004 Dec; 254(6):356-61. PubMed ID: 15538607
    [Abstract] [Full Text] [Related]

  • 19. Negative symptoms, cognitive dysfunction, tardive akathisia and tardive dyskinesia.
    Sachdev P, Hume F, Toohey P, Doutney C.
    Acta Psychiatr Scand; 1996 Jun; 93(6):451-9. PubMed ID: 8831862
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and tolerability of low-dose donepezil in schizophrenia.
    Erickson SK, Schwarzkopf SB, Palumbo D, Badgley-Fleeman J, Smirnow AM, Light GA.
    Clin Neuropharmacol; 2005 Jun; 28(4):179-84. PubMed ID: 16062097
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.